Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide vs Dacarbazine in Metastatic Melanoma
NCT00091572Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Oct 2004
- Primary completion
- Dec 2007
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of temozolomide in melanoma, sponsored by Merck & Co.. Started Oct 2004; status: completed.
02
Drugs
temozolomide
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00091572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00091572.